Polyomavirus small t antigen interacts with Yes-associated protein to regulate cell survival and differentiation

Journal of Virology

Volumn 88, Issue 20, 2014, Pages 12055-12064

  Hwang, Justin H ^a,b   Pores Fernando, Arun T ^c,d   Faure, Nathalie ^a   Andrabi, Shaida ^c,e   Hahn, William C ^c,f   Schaffhausen, Brian S ^a,b   Roberts, Thomas M ^c,d  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF KASHMIR   (India)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TRANSDUCIN REPEAT CONTAINING PROTEIN; ISOBUTYLMETHYLXANTHINE; PHOSPHODIESTERASE INHIBITOR; PHOSPHOPROTEIN PHOSPHATASE 2A; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TEAD; UNCLASSIFIED DRUG; VIRUS MIDDLE T ANTIGEN; VIRUS PROTEIN; VIRUS SMALL T ANTIGEN; YES ASSOCIATED PROTEIN 1; YES ASSOCIATED PROTEIN 2; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; VIRUS T ANTIGEN; YAP1 (YES-ASSOCIATED) PROTEIN, HUMAN;

3T3 CELL LINE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; GENETIC ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; MUTANT; MYOBLAST; NONHUMAN; PHENOTYPE; POLYOMA VIRUS; PROADIPOCYTE; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; ANIMAL; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; MOUSE; PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS;

3T3 CELLS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL DIFFERENTIATION; CELL SURVIVAL; HEK293 CELLS; HUMANS; MICE; MUTAGENESIS, SITE-DIRECTED; PHOSPHOPROTEINS; PHOSPHORYLATION;

EID: 84907912203     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01399-14     Document Type: Article

References (71)

1. Eckhart W, Hutchinson MA, Hunter T. 1979. An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates. Cell 18:925-933. http://dx.doi.org/10.1016/0092-8674(79)90205-8.
2. Cartwright CA, Hutchinson MA, Eckhart W. 1985. Structural and functional modification of pp60c-src associated with polyoma middle tumor antigen from infected or transformed cells. Mol. Cell. Biol. 5:2647-2652.
3. Whitman M, Kaplan DR, Schaffhausen B, Cantley L, Roberts TM. 1985. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature 315:239-242. http://dx.doi.org/10.1038/315239a0.
4. Asselin C, Gelinas C, Branton PE, Bastin M. 1984. Polyoma middle T antigen requires cooperation from another gene to express the malignant phenotype in vivo. Mol. Cell. Biol. 4:755-760.
5. O'Shea CC, Fried M. 2005. Modulation of the ARF-p53 pathway by the small DNA tumor viruses. Cell Cycle 4:449-452. http://dx.doi.org/10.4161/cc.4.3.1555.
6. Andrabi S, Gjoerup OV, Kean JA, Roberts TM, Schaffhausen B. 2007. Protein phosphatase 2A regulates life and death decisions via Akt in a context-dependent manner. Proc. Natl. Acad. Sci. U. S. A. 104:19011-19016. http://dx.doi.org/10.1073/pnas.0706696104.
7. Andrabi S, Hwang JH, Choe JK, Roberts TM, Schaffhausen BS. 2011. Comparisons between murine polyomavirus and Simian virus 40 show significant differences in small T antigen function. J. Virol. 85:10649-10658. http://dx.doi.org/10.1128/JVI.05034-11.
8. Hwang JH, Jiang T, Kulkarni S, Faure N, Schaffhausen BS. 2013. Protein phosphatase 2A isoforms utilizing Abeta scaffolds regulate differentiation through control of Akt protein. J. Biol. Chem. 288:32064-32073. http://dx.doi.org/10.1074/jbc.M113.497644.
9. Tian Y, Li D, Dahl J, You J, Benjamin T. 2004. Identification of TAZ as a binding partner of the polyomavirus T antigens. J. Virol. 78:12657-12664. http://dx.doi.org/10.1128/JVI.78.22.12657-12664.2004.
10. Wang K, Degerny C, Xu M, Yang XJ. 2009. YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease. Biochem. Cell Biol. 87:77-91. http: //dx.doi.org/10.1139/O08-114.
11. Sudol M, Shields DC, Farooq A. 2012. Structures of YAP protein domains reveal promising targets for development of new cancer drugs. Semin. Cell Dev. Biol. 23:827-833. http://dx.doi.org/10.1016/j.semcdb.2012.05.002.
12. Liu C, Huang W, Lei Q. 2011. Regulation and function of the TAZ transcription co-activator. Int. J. Biochem. Mol. Biol. 2:247-256.
13. Varelas X. 2014. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development 141:1614-1626. http://dx.doi.org/10.1242/dev.102376.
14. Zhao B, Li L, Guan KL. 2010. Hippo signaling at a glance. J. Cell Sci. 123:4001-4006. http://dx.doi.org/10.1242/jcs.069070.
15. Nishio M, Otsubo K, Maehama T, Mimori K, Suzuki A. 2013. Capturing the mammalian Hippo: elucidating its role in cancer. Cancer Sci. 104: 1271-1277. http://dx.doi.org/10.1111/cas.12227.
16. Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, Li L, Zheng P, Ye K, Chinnaiyan A, Halder G, Lai ZC, Guan KL. 2007. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21:2747-2761. http://dx.doi.org/10.1101/gad.1602907.
17. Chaulk SG, Lattanzi VJ, Hiemer SE, Fahlman RP, Varelas X. 2014. The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7. J. Biol. Chem. 289:1886-1891. http: //dx.doi.org/10.1074/jbc.C113.529362.
18. Mori M, Triboulet R, Mohseni M, Schlegelmilch K, Shrestha K, Camargo FD, Gregory RI. 2014. Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer. Cell 156: 893-906. http://dx.doi.org/10.1016/j.cell.2013.12.043.
19. Xu MZ, Yao TJ, Lee NP, Ng IO, Chan YT, Zender L, Lowe SW, Poon RT, Luk JM. 2009. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 115:4576-4585. http://dx.doi.org/10.1002/cncr.24495.
20. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, Mu D, Lucito R, Powers S, Lowe SW. 2006. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125:1253-1267. http: //dx.doi.org/10.1016/j.cell.2006.05.030.
21. Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC, Deng CX, Brugge JS, Haber DA. 2006. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc. Natl. Acad. Sci. U. S. A. 103:12405-12410. http://dx.doi.org/10.1073/pnas.0605579103.
22. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R, Brummelkamp TR. 2007. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 17:2054-2060. http://dx.doi.org /10.1016/j.cub.2007.10.039.
23. Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan D. 2007. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130:1120-1133. http://dx.doi.org/10.1016/j.cell.2007.07.019.
24. Wang L, Shi S, Guo Z, Zhang X, Han S, Yang A, Wen W, Zhu Q. 2013. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells. PLoS One 8:e65539. http://dx.doi.org/10.1371/journal.pone.0065539.
25. Shao DD, Xue W, Krall EB, Bhutkar A, Piccioni F, Wang X, Schinzel AC, Sood S, Rosenbluh J, Kim JW, Zwang Y, Roberts TM, Root DE, Jacks T, Hahn WC. 2014. KRAS and YAP1 converge to regulate EMT and tumor survival. Cell 158:171-184. http://dx.doi.org/10.1016/j.cell.2014.06.004.
26. Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D, Kreger BT, Vasioukhin V, Avruch J, Brummelkamp TR, Camargo FD. 2011. Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 144:782-795. http://dx.doi.org/10.1016/j.cell.2011.02.031.
27. Levy D, Adamovich Y, Reuven N, Shaul Y. 2007. The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73. Cell Death Differ. 14:743-751. http://dx.doi.org/10.1038/sj.cdd.4402063.
28. Strano S, Monti O, Pediconi N, Baccarini A, Fontemaggi G, Lapi E, Mantovani F, Damalas A, Citro G, Sacchi A, Del Sal G, Levrero M, Blandino G. 2005. The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA damage. Mol. Cell 18:447-459. http://dx.doi.org/10.1016/j.molcel.2005.04.008.
29. Basu S, Totty NF, Irwin MS, Sudol M, Downward J. 2003. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol. Cell 11:11-23. http://dx.doi.org/10.1016/S1097-2765(02)00776-1.
30. Lee KK, Yonehara S. 2012. Identification of mechanism that couples multisite phosphorylation of Yes-associated protein (YAP) with transcriptional coactivation and regulation of apoptosis. J. Biol. Chem. 287: 9568-9578. http://dx.doi.org/10.1074/jbc.M111.296954.
31. Watt KI, Judson R, Medlow P, Reid K, Kurth TB, Burniston JG, Ratkevicius A, De Bari C, Wackerhage H. 2010. Yap is a novel regulator of C2C12 myogenesis. Biochem. Biophys. Res. Commun. 393:619-624. http://dx.doi.org/10.1016/j.bbrc.2010.02.034.
32. Zhang H, Deo M, Thompson RC, Uhler MD, Turner DL. 2012. Negative regulation of Yap during neuronal differentiation. Dev. Biol. 361:103-115. http://dx.doi.org/10.1016/j.ydbio.2011.10.017.
33. Lin YT, Ding JY, Li MY, Yeh TS, Wang TW, Yu JY. 2012. YAP regulates neuronal differentiation through Sonic hedgehog signaling pathway. Exp. Cell Res. 318:1877-1888. http://dx.doi.org/10.1016/j.yexcr.2012.05.005.
34. Rosenbluh J, Nijhawan D, Cox AG, Li X, Neal JT, Schafer EJ, Zack TI, Wang X, Tsherniak A, Schinzel AC, Shao DD, Schumacher SE, Weir BA, Vazquez F, Cowley GS, Root DE, Mesirov JP, Beroukhim R, Kuo CJ, Goessling W, Hahn WC. 2012. beta-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell 151: 1457-1473. http://dx.doi.org/10.1016/j.cell.2012.11.026.
35. Chen CA, Okayama H. 1988. Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 6:632-638.
36. Morgenstern JP, Land H. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18: 3587-3596. http://dx.doi.org/10.1093/nar/18.12.3587.
37. Zhao B, Ye X, Yu JD, Li L, Li WQ, Li SM, Yu JJ, Lin JD, Wang CY, Chinnaiyan AM, Lai ZC, Guan KL. 2008. TEAD mediates YAPPolyomavirus dependent gene induction and growth control. Genes Dev. 22:1962-1971. http://dx.doi.org/10.1101/gad.1664408.
38. Fluck MM, Schaffhausen BS. 2009. Lessons in signaling and tumorigenesis from polyomavirus middle T antigen. Microbiol. Mol. Biol. Rev. 73: 542-563. http://dx.doi.org/10.1128/MMBR.00009-09.
39. Martens I, Nilsson SA, Linder S, Magnusson G. 1989. Mutational analysis of polyomavirus small-T-antigen functions in productive infection and in transformation. J. Virol. 63:2126-2133.
40. Hao Y, Chun A, Cheung K, Rashidi B, Yang X. 2008. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J. Biol. Chem. 283:5496-5509. http://dx.doi.org/10.1074/jbc.M709037200.
41. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. 2010. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev. 24:72-85. http://dx.doi.org/10.1101/gad.1843810.
42. Yang S, Zhang L, Liu M, Chong R, Ding SJ, Chen Y, Dong J. 2013. CDK1 phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation. Cancer Res. 73:6722-6733. http://dx.doi.org/10.1158/0008-5472.CAN-13-2049.
43. Levy D, Adamovich Y, Reuven N, Shaul Y. 2008. Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol. Cell 29:350-361. http://dx.doi.org/10.1016/j.molcel.2007.12.022.
44. Lau AW, Fukushima H, Wei W. 2012. The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis. Front. Biosci. 17:2197-2212. http://dx.doi.org/10.2741/4045.
45. Mullane KP, Ratnofsky M, Cullere X, Schaffhausen B. 1998. Signaling from polyomavirus middle T and small T defines different roles for protein phosphatase 2A. Mol. Cell. Biol. 18:7556-7564.
46. Benhaddou A, Keime C, Ye T, Morlon A, Michel I, Jost B, Mengus G, Davidson I. 2012. Transcription factor TEAD4 regulates expression of myogenin and the unfolded protein response genes during C2C12 cell differentiation. Cell Death Differ. 19:220-231. http://dx.doi.org/10.1038 /cdd.2011.87.
47. Wilson EM, Tureckova J, Rotwein P. 2004. Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation. Mol. Biol. Cell 15:497-505. http://dx.doi.org/10.1091/mbc.E03-05-0351.
48. Gonzalez I, Tripathi G, Carter EJ, Cobb LJ, Salih DA, Lovett FA, Holding C, Pell JM. 2004. Akt2, a novel functional link between p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in myogenesis. Mol. Cell. Biol. 24:3607-3622. http://dx.doi.org/10.1128/MCB.24.9.3607-3622.2004.
49. Xu Q, Wu Z. 2000. The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells. J. Biol. Chem. 275:36750-36757. http://dx.doi.org/10.1074/jbc.M005030200.
50. Pores Fernando AT, Andrabi S, Cizmecioglu O, Zhu C, Livingston DM, Higgins JM, Schaffhausen BS, Roberts TM. 7 July 2014. Polyoma small T antigen triggers cell death via mitotic catastrophe. Oncogene, in press. http://dx.doi.org/10.1038/onc.2014.192.
51. Fajardo AM, Piazza GA, Tinsley HN. 2014. The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment. Cancers (Basel) 6:436-458. http://dx.doi.org/10.3390/cancers6010436.
52. Sorrentino G, Ruggeri N, Specchia V, Cordenonsi M, Mano M, Dupont S, Manfrin A, Ingallina E, Sommaggio R, Piazza S, Rosato A, Piccolo S, Del Sal G. 2014. Metabolic control of YAP and TAZ by the mevalonate pathway. Nature Cell Biol. 16:357-366. http://dx.doi.org/10.1038/ncb2936.
53. Huang J, Wu S, Barrera J, Matthews K, Pan D. 2005. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell 122:421-434. http://dx.doi.org/10.1016/j.cell.2005.06.007.
54. Wang P, Bai Y, Song B, Wang Y, Liu D, Lai Y, Bi X, Yuan Z. 2011. PP1A-mediated dephosphorylation positively regulates YAP2 activity. PLoS One 6:e24288. http://dx.doi.org/10.1371/journal.pone.0024288.
55. Hong W, Guan KL. 2012. The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway. Semin. Cell Dev. Biol. 23:785-793. http://dx.doi.org/10.1016/j.semcdb.2012.05.004.
56. Vassilev A, Kaneko KJ, Shu H, Zhao Y, DePamphilis ML. 2001. TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Genes Dev. 15:1229-1241. http://dx.doi.org/10.1101/gad.888601.
57. Murakami M, Nakagawa M, Olson EN, Nakagawa O. 2005. A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. Proc. Natl. Acad. Sci. U. S. A. 102:18034-18039. http://dx.doi.org/10.1073/pnas.0509109102.
58. Zaidi SK, Sullivan AJ, Medina R, Ito Y, van Wijnen AJ, Stein JL, Lian JB, Stein GS. 2004. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J. 23:790-799. http://dx.doi.org/10.1038/sj.emboj.7600073.
59. Cui CB, Cooper LF, Yang X, Karsenty G, Aukhil I. 2003. Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. Mol. Cell. Biol. 23:1004-1013. http://dx.doi.org/10.1128/MCB.23.3.1004-1013.2003.
60. Varelas X, Sakuma R, Samavarchi-Tehrani P, Peerani R, Rao BM, Dembowy J, Yaffe MB, Zandstra PW, Wrana JL. 2008. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stemcell self-renewal. Nature Cell Biol. 10:837-848. http://dx.doi.org/10.1038 /ncb1748.
61. Lee MJ, Ran Byun M, Furutani-Seiki M, Hong JH, Jung HS. 2014. YAP and TAZ regulate skin wound healing. J. Invest. Dermatol. 134:518-525. http://dx.doi.org/10.1038/jid.2013.339.
62. Strano S, Munarriz E, Rossi M, Castagnoli L, Shaul Y, Sacchi A, Oren M, Sudol M, Cesareni G, Blandino G. 2001. Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J. Biol. Chem. 276:15164-15173. http://dx.doi.org/10.1074/jbc.M010484200.
63. Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, Donowitz M, Hisaminato A, Fujiwara T, Ito Y, Cantley LC, Yaffe MB. 2000. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 19:6778-6791. http://dx.doi.org/10.1093/emboj/19.24.6778.
64. Barry ER, Morikawa T, Butler BL, Shrestha K, de la Rosa R, Yan KS, Fuchs CS, Magness ST, Smits R, Ogino S, Kuo CJ, Camargo FD. 2013. Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 493:106-110. http://dx.doi.org/10.1038/nature11693.
65. Konsavage WM, Jr, Yochum GS. 2013. Intersection of Hippo/YAP and Wnt/beta-catenin signaling pathways. Acta Biochim. Biophys. Sin. (Shanghai) 45:71-79. http://dx.doi.org/10.1093/abbs/gms084.
66. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. 2005. MicroRNA expression profiles classify human cancers. Nature 435:834-838. http://dx.doi.org/10.1038/nature03702.
67. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT. 2009. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137:1005-1017. http://dx.doi.org/10.1016/j.cell.2009.04.021.
68. Hwang HW, Wentzel EA, Mendell JT. 2009. Cell-cell contact globally activates microRNA biogenesis. Proc. Natl. Acad. Sci. U. S. A. 106:7016-7021. http://dx.doi.org/10.1073/pnas.0811523106.
69. Hao J, Zhang Y, Wang Y, Ye R, Qiu J, Zhao Z, Li J. 2014. Role of extracellular matrix and YAP/TAZ in cell fate determination. Cell. Signal. 26:186-191. http://dx.doi.org/10.1016/j.cellsig.2013.11.006.
70. Xu Y, Chen Y, Zhang P, Jeffrey PD, Shi Y. 2008. Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation. Mol. Cell 31:873-885. http://dx.doi.org/10.1016/j.molcel.2008.08.006.
71. Cho US, Morrone S, Sablina AA, Arroyo JD, Hahn WC, Xu W. 2007. Structural basis of PP2A inhibition by small t antigen. PLoS Biol. 5:e202. http://dx.doi.org/10.1371/journal.pbio.0050202.